Dr. Reddy's Laboratories Ltd. (RDY)
12.34
+0.12
(+0.98%)
USD |
NYSE |
Aug 25, 16:00
12.34
0.00 (0.00%)
Pre-Market: 19:59
Dr. Reddy's Laboratories Total Liabilities (Quarterly) : 1.992B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.992B |
| March 31, 2026 | 2.097B |
| December 31, 2025 | 2.082B |
| September 30, 2025 | 2.026B |
| June 30, 2025 | 1.933B |
| March 31, 2025 | 1.823B |
| December 31, 2024 | 1.863B |
| September 30, 2024 | 1.870B |
| June 30, 2024 | 1.447B |
| March 31, 2024 | 1.283B |
| December 31, 2023 | 1.262B |
| September 30, 2023 | 1.131B |
| June 30, 2023 | 1.094B |
| March 31, 2023 | 1.106B |
| December 31, 2022 | 1.076B |
| September 30, 2022 | 1.042B |
| June 30, 2022 | 1.210B |
| March 31, 2022 | 1.350B |
| December 31, 2021 | 1.244B |
| September 30, 2021 | 1.274B |
| June 30, 2021 | 1.347B |
| March 31, 2021 | 1.264B |
| December 31, 2020 | 1.135B |
| September 30, 2020 | 1.193B |
| June 30, 2020 | 1.185B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.021B |
| December 31, 2019 | 969.85M |
| September 30, 2019 | 1.129B |
| June 30, 2019 | 1.172B |
| March 31, 2019 | 1.230B |
| December 31, 2018 | 1.303B |
| September 30, 2018 | 1.418B |
| June 30, 2018 | 1.466B |
| March 31, 2018 | 1.520B |
| December 31, 2017 | 1.603B |
| September 30, 2017 | 1.534B |
| June 30, 2017 | 985.29M |
| March 31, 2017 | 1.475B |
| December 31, 2016 | 1.564B |
| September 30, 2016 | 1.579B |
| June 30, 2016 | 1.207B |
| March 31, 2016 | 1.198B |
| December 31, 2015 | |
| September 30, 2015 | 1.233B |
| June 30, 2015 | |
| March 31, 2015 | 1.334B |
| December 31, 2014 | |
| September 30, 2014 | 1.252B |
| June 30, 2014 | |
| March 31, 2014 | 1.330B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 49.87B |
| Teva Pharmaceutical Industries Ltd. | 32.10B |
| Novo Nordisk A/S | 57.15B |
| Perrigo Co. Plc | 5.094B |
| Innoviva, Inc. | 469.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.078B |
| Shareholders Equity (Quarterly) | 4.051B |
| Debt to Equity Ratio | 0.1877 |
| Current Ratio | 1.902 |
| Net Debt Paydown Yield | -0.35% |